Treatment selection in depression: The role of clinical judgment

Psychiatric Clinics of North America

Volumn 35, Issue 1, 2012, Pages 87-98

  Tomba, Elena ^a   Fava, Giovanni A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antidepressive agents; Clinical judgment; Clinimetrics; Depressive disorder; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; PLACEBO; SEROTONIN TRANSPORTER;

CLINICAL DECISION MAKING; CLINICAL OBSERVATION; COMORBIDITY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESISTANCE; DRUG TOLERANCE; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; HUMAN; INTERVIEW; MAJOR DEPRESSION; PATIENT ASSESSMENT; PATIENT PREFERENCE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RECURRENT DISEASE; REPEAT PROCEDURE; REVIEW; SELF EVALUATION; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; CLINICAL MEDICINE; CLINICAL PROTOCOLS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DECISION MAKING; DECISION SUPPORT TECHNIQUES; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; HUMANS; JUDGMENT; LIFE STYLE; PATIENT PREFERENCE; PATIENT SELECTION; RECURRENCE; TREATMENT OUTCOME;

EID: 84857401645     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2011.11.003     Document Type: Review

References (46)

1. Feinstein A.R., Horwitz R.I. Problems in the "evidence" of the "evidence-based medicine.". Am J Med 1997, 103:529-535.
2. Fava G.A., Rafanelli C., Tomba E. The clinical approach process in psychiatry: a clinimetric approach. J Clin Psychiatry 2011, DOI: 10.40881JCP.10r06444.
3. Practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2010, 167(October Suppl):1-118. Work Group on Major Depressive Disorder, 3rd edition.
4. Raue P.J., Schulberg H.C., Heo M., et al. Patients' depression treatment preferences and initiation, adherence and outcome: a randomized primary care study. Psychiatr Serv 2009, 60:337-343.
5. Kocsis J.H., Leon A.C., Markowitz J.C., et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009, 70:354-361.
6. Mergl R., Henkel V., Allgaier A.K., et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive behavioral therapy in depressed primary patients?. Psychother Psychosom 2010, 79:131-135.
7. Owens D.K. Improving practice guidelines with patient-specific recommendations. Ann Intern Med 2011, 154:683-684.
8. Tomba E. Nowhere patients. Psychother Psychosom 2012, 81:69-72.
9. Bartova L., Berger A., Pezawas L. Is there a personalized medicine for mood disorders?. Eur Arch Psychiatry Clin Neurosci 2010, 260(Suppl 2):S121-S126.
10. Fava G.A., Tomba E. New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs 2010, 24:453-465.
11. Fava G.A., Tomba E., Grandi S. The road to recovery from depression. Psychother Psychosom 2007, 76:260-265.
12. Zimmerman M., Chelminski I., McDermut W. Major depressive disorder and Axis I diagnostic comorbidity. J Clin Psychiatry 2002, 63:187-193.
13. Emmelkamp P.M.G., Bouman T.K., Scholing A. Anxiety disorders 1993, 55-67. John Wiley, Chichester (UK).
14. Guidi J., Fava G.A., Bech P., et al. The clinical interview for depression. Psychother Psychosom 2011, 80:10-27.
15. Fava G.A., Rafanelli C., Tomba E., et al. Sequential combination of cognitive behavioural treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom 2011, 80:136-143.
16. Leuchther A.F., Cook I.A., Hamilton S.P., et al. Biomarkers to predict antidepressant response. Curr Psychiatry Rep 2010, 12:553-562.
17. Taylor M.J., Sen S., Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry 2010, 68:536-543.
18. Schulthorpe K.D., Douglass A.B. Sleep pathologies in depression and the clinical utility of polysomnography. Can J Psychiatry 2010, 55:413-421.
19. Spielmans G.I., Berman M.I., Usitalo A.N. Psychotherapy versus second generation antidepressants in the treatment of depression. J Nerv Ment Dis 2011, 199:142-149.
20. Fournier J.C., de Rubeis R.S., Hollon S.D., et al. Antidepressant drug effects and depression severity. JAMA 2010, 303:47-53.
21. Looper K.J. Potential medical and surgical complications of serotonergic antidepressant medications. Psychosomatics 2007, 48:1-9.
22. Niewstraten C., Labiris N.R., Holbrook A. Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 2006, 51:300-316.
23. Fabbri S., Fava G.A., Rafanelli C., et al. Family intervention approach to loss of clinical effect during long-term antidepressant treatment. J Clin Psychiatry 2007, 68:1348-1351.
24. Fava G.A., Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuro- Psychopharmacol Biol Psychiatry 2011, 35:1593-1602.
25. Andrews P.W., Kornstein S.G., Haberstadt L.J., et al. Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol 2011, 2:159.
26. van Straten A., Geraedts A., Verdonck-de Leeuw I., et al. Psychological treatment of depressive symptoms in patients with medical disorders. J Psychosom Res 2010, 69:23-32.
27. Leykin Y., Amsterdam J.D., deRubeis R.J., et al. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol 2007, 75:267-276.
28. Kuyken W., Tsivrikos D. Therapist competence, comorbidity and cognitive behavioral therapy for depression. Psychother Psychosom 2009, 78:42-48.
29. Cuijpers P., van Straten A., Hollon S.D., et al. The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression. Acta Psychiatr Scand 2010, 121:415-423.
30. Keller M.B., McCullough J.P., Klein D.N., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000, 342:1462-1470.
31. Guidi J., Fava G.A., Fava M., et al. Efficacy of sequential integration of psychotherapy and pharmacotherapy in major depressive disorder. Psychol Med 2011, 41:321-331.
32. Fava G.A., Ruini C., Rafanelli C., et al. Six year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004, 161:1872-1876.
33. Tomba E. Assessment of lifestyle in relation to health. Adv Psychosom Med 2012, 32:72-96.
34. Fava G.A., Tomba E. Increasing psychological well-being and resilience by psychotherapeutic methods. J Personality 2009, 77:1903-1934.
35. Pigott H.E., Leventhal A.M., Alter G.S., et al. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010, 79:267-279.
36. Judd L.L. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry 1997, 54:989-991.
37. Geddes J.R., Carney S.M., Davies C., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361:653-661.
38. Kaymaz N., Van Os J., Loonen A.J.M., et al. Evidence that patients with single versus recurrent episodes are differentially sensitive to treatment discontinuation. J Clin Psychiatry 2008, 69:1423-1436.
39. Viguera A.C., Baldessarini R.J., Friedberg J. Discontinuing antidepressant treatment in major depression. Harvard Rev Psychiatry 1998, 5:293-306.
40. Moret C., Isaac M., Briley M. Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharmacol 2009, 23:967-974.
41. Fava G.A. Statistical alchemy for drug treatment of generalized anxiety disorder. Psychother Psychosom 2011, 80:261-263.
42. Kupfer D.J., Frank E., Perel J.M. The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 1989, 46:771-775.
43. Simon G.E., von Korff M., Heiligenstein J.H., et al. Initial antidepressant choice in primary care. JAMA 1996, 275:1897-1902.
44. Fava G.A., Bernardi M., Tomba E., et al. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol 2007, 10:835-838.
45. Lichtenberg P., Belmaker R.H. Subtyping major depressive disorder. Psychother Psychosom 2010, 79:131-135.
46. Bech P. Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom 2010, 79:331-338.